Regulatory and Washington

The Dietary Supplements Act (H.R. 5214) would recognize dietary supplement purchases as qualified medical expenses, allowing them to be purchased using health savings accounts and flexible spending accounts.

In response to President Joe Biden unveiling new vaccination mandates for employers with more than 100 employees, FMI and the Consumer Brand Association are responding.

The agency has approved more than 100 generic drugs with the competitive generic therapy designation since it launched the effort in 2017.

The Association for Accessible Medicines’ latest report found that Medicare Part D plans are slow to add new generics to their formularies and often place them on nongeneric pricing tiers.

NACDS has filed an amicus brief with the 8th U.S. Circuit Court of Appeals supporting North Dakota's law regulating PBMs and pointing to recent precedent from the Supreme Court to inform the appeals court's ruling.

National Community Pharmacists Association CEO Doug Hoey, in a roundtable discussion with Health and Human Services Secretary Xavier Becerra, focused on four major priorities for independent pharmacies.

As the keynote speaker of the first Business Program at the virtual 2021 NACDS Annual Meeting, Dr. Scott Gottlieb discussed the industry’s response to the pandemic and sized up what the future holds as vaccinations continue.

The Pharmacy and Medically Underserved Area Enhancement Act would give Medicare patients in medically underserved communities access to critically needed primary health care services delivered by pharmacists.